This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
NZ$73.93
Share price
0.00%
Change (1 day)
115.42%
Change (1 year)
Categories
Market capitalization of Albireo Pharma (ALBO)
Last known market cap: NZ$1.53 Billion
On May 5, 2023 Albireo Pharma had a market cap of NZ$1.53 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Albireo Pharma from 2007 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | NZ$1.44 B | 105.54% |
| 2022 | NZ$0.70 B | 7.09% |
| 2021 | NZ$0.65 B | -33.76% |
| 2020 | NZ$0.99 B | 106.41% |
| 2019 | NZ$0.48 B | 9.93% |
| 2018 | NZ$0.43 B | 36.46% |
| 2017 | NZ$0.32 B | 99.17% |
| 2016 | NZ$0.16 B | 401.59% |
| 2015 | NZ$32.11 M | -19.34% |
| 2014 | NZ$39.81 M | -31.9% |
| 2013 | NZ$58.46 M | 44.35% |
| 2012 | NZ$40.49 M | 33.86% |
| 2011 | NZ$30.25 M | -51.75% |
| 2010 | NZ$62.7 M | -56.06% |
| 2009 | NZ$0.14 B | -27.54% |
| 2008 | NZ$0.19 B | -67.98% |
| 2007 | NZ$0.61 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | NZ$1.63 B | 6.44% | 🇺🇸 USA |